Literature DB >> 27502549

Kidney cancer: Open gates for oxaliplatin.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27502549     DOI： 10.1038/nrurol.2016.150

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.

Authors:  Yanqing Liu; Xiaoli Zheng; Qinqin Yu; Hua Wang; Fuqing Tan; Qianying Zhu; Lingmin Yuan; Huidi Jiang; Lushan Yu; Su Zeng
Journal:  Sci Transl Med       Date:  2016-07-20       Impact factor: 17.956
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.